Sansure Biotech: The Klebsiella pneumoniae and KPC gene detection kit has obtained a registration certificate, valid until 2031.

Sansure Biotech Co., Ltd. announced that its product, the nucleic acid test kit for Klebsiella pneumoniae and the carbapenem-resistant antibiotic resistance gene KPC (fluorescence PCR method), has recently received a Medical Device Registration Certificate issued by the National Medical Products Administration. The certificate number is Guo Zhi Zheng Zhun 20263401295, and the registration category is in domestic Class III in vitro diagnostic reagents, valid until June 21, 2031. The product is used for in vitro qualitative detection of Klebsiella pneumoniae nucleic acid and the carbapenem-resistant antibiotic resistance gene KPC in human sputum specimens.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned